Literature DB >> 27283226

Family history predicts major adverse cardiovascular events (MACE) in young adults with psoriasis.

Alexander Egeberg1, Louise E Bruun2, Lotus Mallbris3, Gunnar H Gislason4, Lone Skov5, Jashin J Wu6, Peter R Hansen2.   

Abstract

BACKGROUND: Patients with psoriasis may have increased risk of major adverse cardiovascular (CV) events (MACE), and a family history of CV disease (CVD) is an independent risk factor for MACE.
OBJECTIVE: We investigated the risk of first-time MACE in patients with psoriasis with or without a family history of CVD.
METHODS: Between January 1, 1997, and December 31, 2011, we identified 2,722,375 individuals, including 25,774 and 4504 patients with mild and severe psoriasis, through administrative registers. Incidence rate ratios were estimated by Poisson regression.
RESULTS: Mean baseline age was 26.6 (SD 8.6) years. A family history of CVD was found among 16,080 (62.4%) and 3009 (66.8%) patients with mild and severe psoriasis, respectively. In patients with psoriasis and a family history of CVD, the adjusted incidence rate ratios (95% CI) of MACE were 1.28 (1.12-1.46) and 1.62 (1.14-2.30) for mild and severe disease, respectively. In patients with psoriasis but without a family history of CVD, there was no increased risk of MACE. LIMITATIONS: Results may not apply to late-onset psoriasis.
CONCLUSIONS: A family history of CVD predicted the risk of first-time MACE in young adults with psoriasis. The findings call for increased focus on a family history of CVD in CV risk assessment of patients with psoriasis.
Copyright © 2016 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cardiovascular disease; epidemiology; family history; inflammation; psoriasis

Mesh:

Year:  2016        PMID: 27283226     DOI: 10.1016/j.jaad.2016.02.1227

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

Review 1.  Double trouble: psoriasis and cardiometabolic disorders.

Authors:  Nasrin Goolam Mahyoodeen; Nigel J Crowther; Mohammed Tikly
Journal:  Cardiovasc J Afr       Date:  2017-12-13       Impact factor: 1.167

2.  Sex differences in the prevalence of vascular disease and risk factors in young hospitalized patients with psoriasis.

Authors:  Michael S Garshick; Georgeta Vaidean; Cyrus A Nikain; Yu Chen; Nathaniel R Smilowitz; Jeffrey S Berger
Journal:  Int J Womens Dermatol       Date:  2019-05-18

3.  Psoriasis Increased the Risk of Adverse Cardiovascular Outcomes: A New Systematic Review and Meta-Analysis of Cohort Study.

Authors:  Lu Liu; Saijin Cui; Meitong Liu; Xiangran Huo; Guoqiang Zhang; Na Wang
Journal:  Front Cardiovasc Med       Date:  2022-03-25

Review 4.  Psoriasis and Co-morbidity.

Authors:  Mina Amin; Erica B Lee; Tsen-Fang Tsai; Jashin J Wu
Journal:  Acta Derm Venereol       Date:  2020-01-30       Impact factor: 3.875

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.